Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The current DSM-oriented diagnostic paradigm has introduced the issue of heterogeneity, as it fails to account for the identification of the neurological processes underlying mental illnesses, which affects the precision of treatment. The Research Domain Criteria (RDoC) framework serves as a recognized approach to addressing this heterogeneity, and several assessment and translation techniques have been proposed. Among these methods, transforming RDoC scores from electronic medical records (EMR) using Natural Language Processing (NLP) has emerged as a suitable technique, demonstrating clinical effectiveness. Numerous studies have sought to use RDoC to understand the Diagnostic and Statistical Manual of Mental Disorders (DSM) categories from a qualified perspective, but few studies have examined the distribution variations and interaction characteristics of RDoC within various DSM categories through retrospective analyses. Therefore, we employed unsupervised learning to translate five domains of eRDoC scores derived from electronic medical records (EMR) of patients diagnosed with Major Depressive Disorder (MDD), Schizophrenia (SCZ), and Bipolar Disorder (BD) at West China Hospital between 2008 and 2021. The distribution characteristics, interaction networks, and potential clinical effectiveness of RDoC domains were analyzed. Using non-parametric statistical tests, we found that MDD had the highest score in Negative Valence System (NVS) (4.1, p < 0.001), while BD exhibited the highest score in Positive Valence System (PVS) score (4.9, p < 0.001) and Arousal System (AS) (4.4, p < 0.001). SCZ demonstrated the highest scores in Cognitive Systems (CS) (5.8, p < 0.001) and Social Processes Systems (SPS) (4.6, p < 0.001). Through Bayesian network (BN) analysis, we identified relatively consistent interaction relationships among various RDoC domains (NVS → AS, NVS → CS, NVS → PVS, as well as CS → SPS; parameter range = 0.156 to 0.635, p < 0.001). Lastly, using logistic regression and Cox proportional hazards models, we demonstrated that AS was significantly associated with the length of hospital stay (-0.21, p < 0.05) and 30-day readmission risk (adjusted odds ratio [aOR] = 0.91, 95% confidence interval [CI] 0.91-0.99) to some extent. In conclusion, we suggest that the eRDoC characteristics varied in different DSM. By Bayesian Network, we found NVS and CS might be potential source in interacting with other system. Furthermore, CS, SPS and AS were associated with the length of stay and 30-days readmission, making them effective for predicting prognosis of psychiatric disorders.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776203PMC
http://dx.doi.org/10.1186/s12888-025-06510-2DOI Listing

Publication Analysis

Top Keywords

clinical effectiveness
12
potential clinical
8
electronic medical
8
medical records
8
records emr
8
dsm categories
8
rdoc
5
interaction network
4
network potential
4
effectiveness dimensional
4

Similar Publications

Importance: This study represents a first successful use of a genetic biomarker to select potential responders in a prospective study in psychiatry. Liafensine, a triple reuptake inhibitor, may become a new precision medicine for treatment-resistant depression (TRD), a major unmet medical need.

Objective: To determine whether ANK3-positive patients with TRD benefit from a 1-mg and/or 2-mg daily oral dose of liafensine, compared with placebo, in a clinical trial.

View Article and Find Full Text PDF

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer.

JAMA Netw Open

September 2025

Oncostat U1018, Institut National de la Santé et de la Recherche Médicale (INSERM), Ligue Contre le Cancer, Paris-Saclay University, Villejuif, France.

Importance: Antibiotics, steroids, and proton pump inhibitors (PPIs) are suspected to decrease the efficacy of immunotherapy.

Objective: To explore the association of comedications with overall survival (OS) in patients with advanced non-small-cell lung cancer (NSCLC).

Design, Setting, And Participants: This nationwide retrospective cohort study used target trial emulations of patients newly diagnosed with NSCLC from January 2015 to December 2022, identified from the French national health care database.

View Article and Find Full Text PDF

Importance: Janus kinase (JAK) inhibitors are highly effective medications for several immune-mediated inflammatory diseases (IMIDs). However, safety concerns have led to regulatory restrictions.

Objective: To compare the risk of adverse events with JAK inhibitors vs tumor necrosis factor (TNF) antagonists in patients with IMIDs in head-to-head comparative effectiveness studies.

View Article and Find Full Text PDF

IntroductionDaratumumab is a therapeutic cornerstone of the management of multiple myeloma, exerting its anti-myeloma activity through targeting of the cell surface glycoprotein CD38 on plasma cells. While originally given intravenously, the subcutaneous formulation, daratumumab hyaluronidase injection (Dara SC), has been associated with non-inferior efficacy and lower infusion-related reaction rates (IRRs) in the treatment of multiple myeloma and light chain amyloidosis. A noted benefit of Dara SC is a short administration time; however, the optimal observation time post injection to ensure patient safety is unclear from the drug labeling.

View Article and Find Full Text PDF

Background: People with dementia who have a fall can experience both physical and psychological effects, often leading to diminished independence. Falls impose economic costs on the healthcare system. Despite elevated fall risks in dementia populations, evidence supporting effective home-based interventions remains limited.

View Article and Find Full Text PDF